In Silico–Based Structural Analysis of Arylthiophene Derivatives for FTase Inhibitory Activity, hERG, and Other Toxic Effects
暂无分享,去创建一个
Pedro A Fernandes | Maria J Ramos | P. Fernandes | M. Ramos | S. Sousa | N S Hari Narayana Moorthy | Sergio F Sousa | N. S. H. Narayana Moorthy
[1] J. Durbin,et al. Testing for serial correlation in least squares regression. I. , 1950, Biometrika.
[2] J. Gasteiger,et al. ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .
[3] N. S. Hari Narayana Moorthy,et al. Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivatives. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).
[4] Pedro Alexandrino Fernandes,et al. Theoretical studies on farnesyltransferase: The distances paradox explained , 2006, Proteins.
[5] Sérgio F. Sousa,et al. Molecular dynamics analysis of farnesyltransferase: A closer look into the amino acid behavior , 2008 .
[6] QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction , 2012, Medicinal Chemistry Research.
[7] N. S. Hari Narayana Moorthy,et al. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives , 2010, Journal of enzyme inhibition and medicinal chemistry.
[8] P. Fernandes,et al. Structural feature study of benzofuran derivatives as farnesyltransferase inhibitors , 2011, Journal of enzyme inhibition and medicinal chemistry.
[9] P. Angibaud,et al. Farnesyl protein transferase inhibitor ZARNESTRA R115777 - history of a discovery. , 2003, Current topics in medicinal chemistry.
[10] QSAR and pharmacophore analysis of thiosemicarbazone derivatives as ribonucleotide reductase inhibitors , 2012, Medicinal Chemistry Research.
[11] D. Heimbrook,et al. Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channel. , 2004, Journal of medicinal chemistry.
[12] Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? , 2004, Journal of medicinal chemistry.
[13] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[14] P. Casey,et al. Cocrystal structure of protein farnesyltransferase complexed with a farnesyl diphosphate substrate. , 1998, Biochemistry.
[15] N. S. Hari Narayana Moorthy,et al. Quantitative structure-activity relationships of selective antagonists of glucagon receptor using QuaSAR descriptors. , 2006, Chemical & pharmaceutical bulletin.
[16] R. Doll,et al. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336. , 2001, Current medicinal chemistry.
[17] P. Roy,et al. On Some Aspects of Variable Selection for Partial Least Squares Regression Models , 2008 .
[18] Pedro Alexandrino Fernandes,et al. Theoretical studies on farnesyl transferase: Evidence for thioether product coordination to the active‐site zinc sphere , 2007, J. Comput. Chem..
[19] Márcia M. C. Ferreira,et al. Basic validation procedures for regression models in QSAR and QSPR studies: theory and application , 2009 .
[20] A. Tropsha,et al. Beware of q 2 , 2002 .
[21] P. K. Basniwal,et al. 2-(4-aminophenyl) benzothiazole: a potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. , 2006, Mini reviews in medicinal chemistry.
[22] V. D. da Silva,et al. Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase inhibitors in cancer therapy. , 2010, Journal of molecular graphics & modelling.
[23] J. Durbin,et al. Testing for serial correlation in least squares regression. II. , 1950, Biometrika.
[24] C. Leem,et al. A novel hypothesis for the binding mode of HERG channel blockers. , 2006, Biochemical and biophysical research communications.
[25] Pedro Alexandrino Fernandes,et al. Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme. , 2009, Bioorganic & medicinal chemistry.
[26] M. Sakaitani,et al. Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[27] C. Karthikeyan,et al. QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors , 2009 .
[28] P. Fernandes,et al. QSAR Analysis of Isosteviol Derivatives as α-Glucosidase Inhibitors with Element Count and Other Descriptors , 2011 .
[29] J. Dubois,et al. Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series. , 2009, Journal of medicinal chemistry.
[30] P. Fernandes,et al. Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: A quantitative structure-activity relationship (QSAR) Study , 2011, Journal of enzyme inhibition and medicinal chemistry.